Literature DB >> 10988295

Structure/Function analysis of p55 tumor necrosis factor receptor and fas-associated death domain. Effect on necrosis in L929sA cells.

E Boone1, T Vanden Berghe, G Van Loo, G De Wilde, N De Wael, D Vercammen, W Fiers, G Haegeman, P Vandenabeele.   

Abstract

Tumor necrosis factor (TNF) induces a typical apoptotic cell death program in various cell lines by interacting with the p55 tumor necrosis factor receptor (TNF-R55). In contrast, triggering of the fibrosarcoma cell line L929sA gives rise to characteristic cellular changes resulting in necrosis. The intracellular domain of TNF-R55 can be subdivided into two parts: a membrane-proximal domain (amino acids 202-325) and a C-terminal death domain (DD) (amino acids 326-413), which has been shown to be necessary and sufficient for apoptosis. Structure/function analysis of TNF-R55-mediated necrosis in L929sA cells demonstrated that initiation of necrotic cell death, as defined by swelling of the cells, rapid membrane permeabilization, absence of nuclear condensation, absence of DNA hypoploidy, and generation of mitochondrial reactive oxygen intermediates, is also confined to the DD. The striking synergistic effect of the caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone on TNF-induced necrosis was also observed with receptors solely containing the DD. TNF-R55-mediated necrosis is not affected by the dominant negative deletion mutant of the Fas-associated death domain (FADD-(80-205)) that lacks the N-terminal death effector domain. Moreover, overexpression of FADD-(80-205) in L929sA is cytotoxic and insensitive to CrmA, while the cytotoxicity due to overexpression of the deletion mutant FADD-(1-111) lacking the DD is prevented by CrmA. These results demonstrate that the death domain of FADD can elicit an active necrotic cell death pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10988295     DOI: 10.1074/jbc.M007166200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  The p55 tumour necrosis factor receptor TNFR1 contains a trans-Golgi network localization signal in the C-terminal region of its cytoplasmic tail.

Authors:  Helen Storey; Abigail Stewart; Peter Vandenabeele; J Paul Luzio
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

2.  CrmA protects against apoptosis and ceramide formation in PC12 cells.

Authors:  Raja Goswami; John Kilkus; Bobbie Scurlock; Glyn Dawson
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

3.  Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production.

Authors:  Greet Brouckaert; Michael Kalai; Dmitri V Krysko; Xavier Saelens; Dominique Vercammen; Matladi N Ndlovu; 'Matladi Ndlovu; Guy Haegeman; Katharina D'Herde; Peter Vandenabeele
Journal:  Mol Biol Cell       Date:  2003-12-10       Impact factor: 4.138

4.  Caspase-10-dependent cell death in Fas/CD95 signalling is not abrogated by caspase inhibitor zVAD-fmk.

Authors:  Elodie Lafont; Delphine Milhas; Justin Teissié; Nicole Therville; Nathalie Andrieu-Abadie; Thierry Levade; Hervé Benoist; Bruno Ségui
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

5.  Safe eradication of large established tumors using neovasculature-targeted tumor necrosis factor-based therapies.

Authors:  Leander Huyghe; Alexander Van Parys; Anje Cauwels; Sandra Van Lint; Stijn De Munter; Jennyfer Bultinck; Lennart Zabeau; Jeroen Hostens; An Goethals; Nele Vanderroost; Annick Verhee; Gilles Uzé; Niko Kley; Frank Peelman; Bart Vandekerckhove; Peter Brouckaert; Jan Tavernier
Journal:  EMBO Mol Med       Date:  2020-01-08       Impact factor: 12.137

6.  Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/TCF4(TCF7L2)-dependent pathway.

Authors:  W P Cawthorn; F Heyd; K Hegyi; J K Sethi
Journal:  Cell Death Differ       Date:  2007-04-20       Impact factor: 15.828

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.